Episodes

  • "Every trip is a learning experience" Advice from travel-loving T1D parents, Sarah Steward Holland and Nicholas Holland

    "Every trip is a learning experience" Advice from travel-loving T1D parents, Sarah Steward Holland and Nicholas Holland
    May 12 2026

    Let's talk travel!

    It's that time of year when we start getting ready for family vacations and trips big and small. Whether you're driving to the beach for a long weekend, heading to a week-long family reunion or taking that dream vacation overseas, diabetes makes everything just a little bit more complicated.

    I'm talking to Sarah Stewart Holland and Nicholas, parents of three boys, one with type 1. Nicholas has put together a great travel guide and we have a helpful and eye opening conversation about taking T1D along for the ride.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Check out the Holland's travel guide here

    Learn more about our upcoming in-person events like Moms' Night Out and Club 1921 here

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    50 mins
  • In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more!

    In the News.. Tzield approved for toddlers, generic Ozempic, Omnipod & Tandem updates, T1D Barbie honored... and more!
    May 5 2026
    It's In The News - where we bring you the top diabetes stories and headlines happening now. This week, Tzield approved down to age one and over, Omnipod trials for fully closed loop, Tandem approved for pregnancy, Eversense 365 launches in Europe, generic Ozempic in Canada, an award for the T1D Barbie and more. Announcing Community Commericals! Learn how to get your message on the show here. Don't miss our in-person events: www.diabetes-connections.com/events Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com Okay.. our top story this week: XX The U.S. Food and Drug Administration (FDA) approved Tzield (teplizumab-mzwv) for use in children in stage 2 type 1 diabetes (T1D) ages one and older. The approval expands the previous indication from those aged eight and above and was granted under a priority review process. This decision is supported by one-year data from the PETITE-T1D Phase IV study, which evaluated the safety and pharmacokinetics of Tzield in children under eight years old. Tzield was approved for use in individuals 8+ in stage 2 T1D in 2022. Since then, we have been working to expand the eligible population. This expansion effort includes individuals in stage 3 T1D, who can preserve endogenous insulin production for longer when they take Tzield and, most notably today, children in stage 2. https://www.breakthrought1d.org/news-and-updates/tzield-approved-for-children-ages-one-and-older-in-stage-2-t1d/ XX Big write up in the journal Pediatrics about screening for type 1. Citing the 2025 ADA Standards of Care in Diabetes, the opinion piece talks about how to engage the greater healthcare community. It says: We aim to encourage the development of strategies to emphasize the importance of T1D early detection, integrate screening into routine health care encounters, and support implementation of T1D screening. Pediatricians and other primary care clinicians are well positioned for greater collaboration with the multidisciplinary team, ensuring early detection, timely intervention, and improved outcomes. https://publications.aap.org/pediatricsopenscience/article/2/2/1/207272/Type-1-Diabetes-Screening-in-Pediatrics-Putting?autologincheck=redirected XX More info about GLP-1 drugs and people with type 1. New study shows off label use did not lead to DKA or pancreatitis in a large 1-year single-center study. Moreover, GLP-1 agonist use in people with T1D was associated with lower overall rates of hospitalization, as has occurred in type 2 diabetes Although GLP-1 agonists are not approved by the FDA for T1D management, off-label adjunctive use has risen for those with obesity. Semaglutide was the most commonly-used GLP-1 (65.5% of GLP-1 users) followed by tirzepatide (23.5%). The rest were using the older-generation drugs: liraglutide or dulaglutide. Lots more information to come on type 1 and glp 1-s in upcoming studies. https://www.medscape.com/viewarticle/use-glp-1s-type-1-diabetes-not-linked-increased-dka-2026a1000d56 XX Health Canada ‌​has approved the first generic ​version of ​Danish ⁠drugmaker ⁠Novo ‌Nordisk's Ozempic drug. In January 2026, the Canadian patent for Ozempic will expire, paving the way for cheap generic versions of the semaglutide injections that help regulate blood sugar levels and appetite. Health Canada said this generic, like existing products, is indicated to be used for the "once-weekly treatment of adult patients with Type 2 diabetes to manage blood sugar levels." With three generics on the market, Tadrous said the price could drop to about $100 or less, depending on their dose. Health Canada said it's currently reviewing eight other generic submissions by different companies and expects to make a decision on these in the next few weeks and months. https://www.cbc.ca/news/health/ozempic-generic-health-canada-9.7180566 XX Insulet has enrolled the first participant in a pivotal study for its fully closed-loop (FCL)A automated insulin delivery (AID) system for type 2 diabetes (T2D The participants are between 18 – 75 years of age, living with T2D and using insulin (basal-bolus or basal-only). The Company received Investigational Device Exemption (IDE) approval in March 2026 from the U.S. Food and Drug Administration (FDA). The Company plans to submit a 510(k) filing to the FDA in 2027 and launch its FCL AID system for T2D in 2028. XX insulet Corporation (PODD) has initiated a voluntary recall of certain lots of its ...
    Show More Show Less
    14 mins
  • Inside Tandem's Next Chapter: Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup

    Inside Tandem's Next Chapter: Tubeless Mobi, 7-Day Wear & More with VP of Product Management Marisa Fienup
    May 1 2026

    This week on Diabetes Connections.. an update from Tandem Diabetes. Quite a few approvals and advances have already happened for Tandem this year, as the company looks ahead to the launch of their latest product, the Mobi Tubeless, not yet FDA approved. I'm talking to Marisa Fienup VP of Product Management about how this product is different from the original Mobi, the incorporation of the approved 7-day infusion set, asking your questions and more.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    42 mins
  • The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice

    The Fight to Save Levemir: Inside the Grassroots Push to Protect Insulin Choice
    Apr 28 2026

    In 2024 Novo Nordisk announced it would discontinue Levimir insulin.. leaving many people scrambling and kind of stunned. There's no other insulin on the market quite like this long-acting – and it turns out the community wasn't letting it go without a fight.

    My guests are going to tell you more about why. I'm taking to Alison Smart, founder of The Alliance to Protect Insulin Choice – her daughter lives with type 1 as well as two doctors: Florence Brown and Amy Valent. Dr. Brown is Co-Director Joslin and BIDMC Diabetes in Pregnancy Program, Assistant Professor of Medicine, Harvard Medical School. Dr. Valent Assistant Professor of Obstetrics and Gynecology, School of Medicine at Oregon Health and Science University.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    35 mins
  • BONUS Episode: TempraMed wants to pair smart insulin tracking with temperature protection

    BONUS Episode: TempraMed wants to pair smart insulin tracking with temperature protection
    Apr 24 2026

    I've been talking to the folks at VIVI Cap for a few years now, it's been fun watching their progress. I wanted to catch up and find out more about what they've been up to when it comes to insulin storage – especially as we get closer to the hot summer months. They launched new products in the last year – smart insulin storage that helps you track dosing and a new case with more cooling protection.

    My guest is Ron Nagar, the founder and CEO of TempraMed, the company that makes the VIVI Cap.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    21 mins
  • In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!

    In the News.. Stem Cell Research Update, New Patch Pump Approved, GLP-1 Resistance Studied, Big Win T1D School Kids and more!
    Apr 21 2026

    It's In the News! Every other week we bring you the top diabetes stories and headlines happening now. This week's top stories: stem cell reserach updates, the Pivot patch pump gets FDA approval, GLP-1 Resistance research moves forward, T1D kids in VA get a big win, time of day for exercise matters, and much more!

    Don't miss our 2026 events - Club 1921 and Moms' Night Out info here

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    11 mins
  • Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM

    Eversense 365: Pump Integration and Real-Life Use For the One-Year CGM
    Apr 14 2026

    We've got an update on Eversense—the CGM that sits just below the skin and lasts a year. This is the first time we're talking to the folks from Senseonics, the company that makes Eversense, since they spun off from Ascensia. What's changed? It's also the first time, we're talking to someone who uses Eversense with an insulin pump – it's now compatible with the twiist pump. I ask your questions about all of this – how's the pump integration in real life, when will the next iterations of Eversense be out, their success in the type 2 market and much more.

    We're talking to Chief Commerical Officer Brian Hansen and Paris Hicks, a woman who uses the twiist system with the Eversense 365 CGM.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    48 mins
  • More Than Babysitting: The Power of Type One Together with Raquel Baron

    More Than Babysitting: The Power of Type One Together with Raquel Baron
    Apr 10 2026

    Today on Diabetes Connections.. a bonus episode all about finding support and community online and in real life. Seems to be a theme lately and I could NOT be happier. Type One Together started with one college student, a few babysitting jobs, and a realization that there was a need.

    Type One Together has become something much bigger – they'll still help you find a sitter but they're also a hub for T1D info, support and gatherings. I'm talking to the founder, Raquel Baron, about how they got there, what kind of help they provide and what's next.

    This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

    More about Type One Together's events here - use promo code "connections" to save

    Announcing Community Commericals! Learn how to get your message on the show here.
    Learn more about studies and research at Thrivable here
    Please visit our Sponsors & Partners - they help make the show possible!
    Omnipod - Simplify Life
    All about Dexcom
    All about VIVI Cap to protect your insulin from extreme temperatures

    The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:
    Sign up for our newsletter here

    Here's where to find us:
    Facebook (Group)
    Facebook (Page)
    Instagram
    Check out Stacey's books!

    Learn more about everything at our home page www.diabetes-connections.com

    Show More Show Less
    32 mins